FDA 483 - Gehring-Montgomery, Inc. - February 09, 2024

Gehring-Montgomery, Inc. in Warminster, PA, a packer, was cited for three observations during an FDA inspection. The firm failed to adequately investigate and remediate quality issues with components, lacked established recall procedures for distributed products, and did not provide CGMP training to its employees. These issues indicate significant deficiencies in quality control and regulatory compliance.